1/17
Vocabulary flashcards covering the principles of homeostasis, negative feedback mechanisms, and blood glucose regulation as described in the lecture notes.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Homeostasis
The maintenance of the internal environment within certain limits, including pH, carbon dioxide concentration, blood glucose, body temperature, and water balance.
Body Temperature Range
The normal physiological limit typically maintained between 36−38∘C.
Blood Glucose Concentration Range
The normal physiological limit typically maintained between 75−95mg/dL.
Carbon Dioxide (CO2) Concentration Range
The normal physiological limit typically maintained between 35−45mmHg.
Blood pH Level Range
The normal physiological limit typically maintained between 7.35−7.45.
Internal Environment
The environment formed by the blood and tissue fluids.
Negative Feedback
The most common mechanism for regulating physiological processes where the response is opposite to the original stimulus to return the system to a set point.
Receptors
Specialized structures that detect changes within internal conditions.
Coordinator
A central component that receives information from receptors and determines the level of response needed.
Effector
A specialized component that produces the response behavior based on the decision relayed by the coordinator.
Alpha Cells
Pancreatic cells that detect low glucose levels and secrete the hormone glucagon.
Beta Cells
Pancreatic cells that detect high glucose levels and secrete the hormone insulin.
Insulin
A hormone that signals cells to accelerate the conversion of glucose to glycogen for storage in the liver when blood sugar is high.
Glucagon
A hormone that binds to liver cells to signal the conversion of glycogen into glucose when blood sugar is low.
Glycogen
The insoluble form of glucose stored in the liver.
Diabetes Mellitus in Mexico
A condition affecting more than 18% of the population (approximately 14.6 million people) as of June 2023.
Undiagnosed Diabetes Trend
In Mexico, the prevalence of undiagnosed diabetes decreased from 7.1% to 5.8% between 2006 and 2022.
Diabetes and COVID-19 risk
Patients with type 1 and 2 diabetes face substantially higher risks of fatal outcomes or intensive care treatment when infected with COVID-19.